ChartMill assigns a Buy % Consensus number of 46% to ZSAN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-23 | BTIG | Downgrade | Buy -> Neutral |
| 2021-03-15 | Maxim Group | Maintains | Buy |
7 analysts have analysed ZSAN and the average price target is 21.42 null. This implies a price increase of 3741.46% is expected in the next year compared to the current price of 0.5576.
The consensus rating for Zosano Pharma Corporation (ZSAN) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.